C113H129N31O6 — CID 158750625
5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide (PubChem CID 158750625) has the molecular formula C113H129N31O6 and a molecular weight of 2017.49 g/mol. Its IUPAC name is 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide.
| Compound Name | 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide |
|---|---|
| PubChem CID | 158750625 |
| Molecular Formula | C113H129N31O6 |
| Molecular Weight | 2017.49 g/mol |
| Exact Mass | 2016.07 |
| IUPAC Name | 5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide |
| SMILES | CN1CCN(Cc2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(CN6CCC(O)CC6)c5)cc34)cn2)CC1.CN1CCN(Cc2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(CN6CCC6)c5)cc34)cn2)CC1.CN1CCN(Cc2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(N6CCOCC6)c5)cc34)cn2)CC1.O=C(Nc1ccc(CN2CCC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCC4)c3)cc12 |
| InChI | InChI=1S/C30H36N8O2.C28H32N8O2.C28H32N8O.C27H29N7O/c1-36-10-12-38(13-11-36)20-25-4-3-24(18-32-25)33-30(40)29-27-15-22(2-5-28(27)34-35-29)23-14-21(16-31-17-23)19-37-8-6-26(39)7-9-37;1-34-6-8-35(9-7-34)19-23-4-3-22(17-30-23)31-28(37)27-25-15-20(2-5-26(25)32-33-27)21-14-24(18-29-16-21)36-10-12-38-13-11-36;1-34-9-11-36(12-10-34)19-24-5-4-23(17-30-24)31-28(37)27-25-14-21(3-6-26(25)32-33-27)22-13-20(15-29-16-22)18-35-7-2-8-35;35-27(30-22-5-6-23(29-16-22)18-34-10-3-11-34)26-24-13-20(4-7-25(24)31-32-26)21-12-19(14-28-15-21)17-33-8-1-2-9-33/h2-5,14-18,26,39H,6-13,19-20H2,1H3,(H,33,40)(H,34,35);2-5,14-18H,6-13,19H2,1H3,(H,31,37)(H,32,33);3-6,13-17H,2,7-12,18-19H2,1H3,(H,31,37)(H,32,33);4-7,12-16H,1-3,8-11,17-18H2,(H,30,35)(H,31,32) |
| InChIKey | INKWUBFITXMIOV-UHFFFAOYSA-N |
| XLogP | 13.13 |
| TPSA | 399.34 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 150 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2017.49 |
| LogP ≤ 5 | 13.13 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 29 |